Rae Zhang specializes in life science & healthcare; regulatory compliance, PE/VC, M&A, and ESG.

Rae Zhang is the legal counsel of many multi-national and biotech companies in Mainland China, including Boehringer Ingelheim, Sanofi, MSD, GSK, Novartis, Daiichi Sankyo, Medtronic, Zai Lab, Nhwa, Gensci, Jemincare, etc.

Rae Zhang has rich legal and regulatory compliance experiences in the healthcare industry involving prescription medicine, OTC, CxO, medical device, biopharmaceuticals, health foods, clinical supply, vaccine, animal health and hospitals, etc.

Rae Zhang joined Global Law Office in 2017.

Admitted in the PRC

2015-2016 The London School of Economics and Political Science, LL.M.

2014-2017, East China University of Political Science and Law, LL.M.

2010-2014 East China University of Political Science and Law, Bachelor of Law

Rae Zhang has been recognized by the The Legal 500 as Leading Associate of Year 2025; and as Leading Associate and Recommended in life science & healthcare of Year 2026.

ESG Compliance for Healthcare Globalization Chapter 5 Human Genetic Resources and Biosafety